Loading viewer...
earnings
Format: PDF earnings
Incyte Corporation's third-quarter 2016 financial and corporate update presented November 1, 2016, covering Jakafi sales growth, regulatory milestones for baricitinib, and pipeline advancement across JAK inhibitors and immuno-oncology programs. The presentation outlines the company's 2016 financial guidance and strategic expectations for product development timelines and market opportunities.
earnings
21 Pages
earnings
19 Pages
Myriad Genetics
Dr. Reddy's Laboratories Q2 FY17 Press Presentation 2016
earningsearnings
15 Pages
Dr. Reddy's Laboratories
Thompson Creek Metals Q2 2016 Financial Results August 2016
earningsearnings
31 Pages
Thompson Creek Metals Company